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osting by EAbstract Ischemic mitral regurgitation (IMR) results from left ventricular remodelling after myo-
cardial infarction and severely affects cardiovascular mortality and morbidity. Ischemic mitral valve
regurgitation also represents a negative prognostic factor for long-term survival in patients under-
going surgical myocardial revascularization. While severe mitral regurgitation should always be cor-
rected during a coronary artery bypass operation, the decision making is more difﬁcult in patients
with a moderate degree of regurgitation. In this review, we wish to highlight the negative impact of
IMR on long-term survival and discuss the available evidence for surgical correction of IMR at the
time of coronary revascularization.
ª 2010 King Saud University. All rights reserved.Contents
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lsevier1. Discussion
1.1. Pathophysiology of ischemic mitral regurgitation (IMR)
When discussing chronic IMR in the literature and attaching
that label to a patient’s condition, one should use a deﬁnition
that is as speciﬁc as possible in order to ensure the exclusion of
other aetiologies for mitral regurgitation (myxomatous, rheu-
matic, infectious, or congenital).
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Figure 1 Ischemic MR development of heart failure.
116 H.K. Najm et al.Chronic ischemic mitral regurgitation (IMR) is a common
complication of myocardial infarction and severely affects car-
diovascular mortality and morbidity (Milano et al., 2008).
Multiple pathophysiologic mechanisms, such as left ventricular
(LV) remodelling and dysfunction, annular dilation/dysfunc-
tion, and mechanical dyssynchrony, are involved in generating
IMR, each of them having different weight. IMR usually oc-
curs with occlusion of the right coronary or left dominant cir-
cumﬂex coronary arteries, causing an infarction involving the
posterior ventricular wall and posterior PM (Milano et al.,
2008). Anatomically the mitral valve suspensory apparatus is
with two papillary muscles, the antero-lateral and the poste-
ro-medial and both are attached to the ventricular free wall
and not the ventricular septum. The involvement of the ante-
rior PM is less common because of its dual blood supply from
both the left anterior descending coronary artery and a diago-
nal or obtuse marginal coronary artery (Milano et al., 2008;
Zoghbi et al., 2003).
Since ischemic mitral regurgitation is a result of myocardial
injury and regional wall abnormality, the valve leaﬂets and
sub-valvular apparatus are usually structurally normal. The
size, location and transmurality of the myocardial infarctions
determine the severity and the clinical manifestation of the
regurgitation. As a result of the MI, the infracted myocardium
bulges outward and pulls the suspensory elements of the mitral
valve with it, causing tethering of the suspensory chordai, com-
monly the postero-medial papillary muscle causing inability of
the leaﬂet to move freely to each other and coapt leading to
central leak of which the degree is determined by the tethering
forces (Image 1).
By echocardiography we could see that there is asymmetric
restriction of the posterior mitral leaﬂet and pseudo-prolapse
of the anterior mitral leaﬂet. Moderate mitral regurgitation
is then deﬁned as regurgitant volume of 45–59 ml/beat, regur-
gitant fraction 40–49%, and an effective regurgitant oriﬁce of
20–30 mm2 (Zoghbi et al., 2003).
1.2. Impact of ischemic moderate MR on survival and functional
class
The appearance of ischemic mitral regurgitation during myo-
cardial infarction has been studied extensively and found thatImage 1 2D echo showing the central leak of the mitral valve.for mild MR there has been no evidence of detrimental effect
on survival or functional class and can be treated by CABG
alone and that sever MR it has a detrimental effect on both
survival and functional class and should be corrected at the
time of CABG, however, the question remains on whether
moderate IMR should be addressed during surgical revascular-
ization? (Bonow et al., 2006).
The aim of the surgical treatment of IMR should be to im-
prove or abolish MR, in order to improve functional class and
quality of life, promotion of LV remodelling and ﬁnally
achieve survival beneﬁt. Grigioni and co-workers (Fig. 1) from
the mayo clinic has clearly demonstrated that there is a detri-
mental effect of increasing degree of regurgitation as measured
by the effective regurgitant oriﬁce in patients who suffered
myocardial infarction. This was shown in a step-wise fashion
where the ERO of >20 mm2 had lower survival compared
to those below 20 (47% vs. 61%, p= 0.0001) in addition the
development of congestive heart failure was increased from
18% to 46% (p= 0.001) (Grigioni et al., 2001; Bursi et al.,
2005). This has also been conﬁrmed in a later publication from
the same group, looking at a larger number of patients who
suffered myocardial infarction and concluded that the presence
of IMR affects the survival and functional class after MI (Bur-
si et al., 2003) (Fig. 2).
Sirivella and colleagues studied the presence of grade II MR
after CABG in 328 patients and found an increased incidence
of congestive heart failure (CHF), during the 10 years follow
up reaching almost 80% compared to 20% when MR is ab-
sent. Similarly, the survival was decreased from 60% to 20%
during the same follow up (Sirivella and Gielchinsky, 2006).
This ﬁnding was also conﬁrmed by Grossi and colleagues
where 264 patients with moderate MR undergoing CABG
where compared to 1137 with mild and 841 with no MR and
found that risk factors for early mortality and long-term sur-
vival was renal disease, lower ejection fraction, age, prior oper-
ation, stroke and more importantly the MR category (Colvin
Jorde et al., 2006). Beeri and colleagues in an animal study,
where myocardial infarction (MI) and MR was induced. They
compared the repaired vs. non-repaired group and found that
those who had repaired mitral valve have shown decreased end
diastolic volume (Beeri et al., 2007). Furthermore, Tekumit
et al. (2009) demonstrated that ring annuloplasty in chronic
ischemic MR reduces LV end diastolic and end systolic diam-
eters and improves NYHA functional class and concluded that
if left uncorrected during isolated coronary bypass grafting,
Figure 2 IMR impact on survival.
Moderate ischemic mitral regurgitation: Is there a case for early intervention? 117mild to moderate mitral regurgitation will decrease the event
free survival (45.7% vs. 64.7%, p= 0.024) and increase class
III and IV NYHA class (20% vs. 8.1%, p= 0.004) during a
follow up period of 6 years in a matched patients (Mallidi,
2004; Aklog et al., 2001; Tekumit et al., 2009).
Kim et al. studied when revascularization alone was
compared with revascularization and mitral valve repair in
355 patients with ischemic MR, there was a reduction in the
degree of MR in the repair group (11% vs. 89%, p= 0.001),
proving the effectiveness of repairing ischemic MR, neverthe-
less this has not translated into improved survival (41% vs.
44%, p= 0.53) during a follow up period of 5 years (Kim,
2005). In another studies were a comparison were made be-
tween medical, percutaneous coronary intervention, CABG
and CABG with MV repair, they found clear survival advan-
tage of all interventions compared to medical therapy, never-
theless there was no difference between the interventional
groups in survival after 5 years (Harris et al., 2002; Trichon
et al., 2003).
One of the other major issues is the evaluation of the MR in
anaesthetized patient, and without taking in-consideration the
hemodynamic impact of the anesthesia on the severity of the
MR. Aklog et al. examined patients who underwent evaluation
by trans-esophageal echocardiography during CABG, and
found those who were labeled ‘‘non-surgical’’ had a grade low-
er during anesthesia of 1.4 compared to grade 3 before surgery,
nevertheless in the follow up period the regurgitation grade
came up again to 2.3 and concluded that CABG alone will
not correct moderate MR. In addition they advised to evaluate
the grade of MR preoperatively rather than under anesthesia
(Aklog et al., 2001). Dahlberg et al. (2003) from the mayo
clinic correlated the pre discharge echo with survival and
found that those who were discharged with grade II MR will
have worse prognosis and in addition they found that the fail-
ure rate in complex repairs are higher and advised mitral
replacement in case complex repair is needed. This has been
conﬁrmed by Gillinov et al. from the Cleveland clinic, who
indicated that survival was better in the repair group (58%
vs. 36%, p= 0.08) after 5 years and freedom from failure is
91% (Gillinov, 2001; Penicka et al., 2009; Daimon et al.,
2006; Hung et al., 2004).
Penicka et al. they followed up a 135 patients with IMR
who underwent CABG only. They found that 64 patients werefailed to improve at 12 month follow up, and they concluded
that an improvement in moderate IMR by isolated CABG
was observed only in patients with concomitant presence of
viable myocardium and absence of dyssynchrony between pap-
illary muscles (Penicka et al., 2009; Braun et al., 2008).
On the issue of late failure of ischemic mitral valve repair,
the failure was thought to be related to tethering height of
more than 11 mm as measured by pre-op echo, which is the
distance from the annular plane to the coaptation point. In
such cases of increased tethering, it is advised to replace the
valve since restrictive annuloplasty may not have a durable
effect (Daimon et al., 2006). In another study to examine the
mechanism of recurrent ischemic MR, Duran and colleagues
found the only independent predictor of recurrent late post
operative MR was left ventricular sphericity index at end
systole, conﬁrming the that the etiology of IMR is the left
ventricle and it is a ‘‘moving target’’ in patients with ischemic
heart disease. Therefore achieving a competent valve in certain
dimensions may not hold competent in a changing sphericity
index (Hung et al., 2004) (Image 2).
And ﬁnally on the selection of which valve repair technique
is better for an IMR, Braun et al. in their study group of the
use of restrictive annuloplasty in ischemic mitral regurge and
coronary revascularization, they concluded that at 4.3 years’
follow up, intermediate-term cut-off values for left ventricular
reverse remodelling proved to be predictors for late mortality.
For patients with preoperative LVEDD of 65 mm or less,
restrictive mitral annuloplasty with revascularization provides
a cure for ischemic mitral regurgitation and heart failure; how-
ever, when LVEDD exceeds 65 mm, outcome is poor and a
ventricular approach should be considered (Braun et al.,
2008) (Image 3).2. Conclusions
We can conclude from this review that there are two schools of
thoughts regarding the surgical strategies for the treatment of
moderate IMR. The ﬁrst school, advocate more liberal use of
mitral repair at the time of revascularization. The rationale is
that CABG alone will leave many patients with signiﬁcant
residual MR, which will have a signiﬁcant impact on survival
and functional status. And the other school of surgeons who
Image 2 3D image of the mitral valve from the left ventricle.
Image 3 3D echo of the mitral valve from the left atrial side-showing the lack of coaptation.
118 H.K. Najm et al.favor CABG alone to treat moderate IMR argue that the
recurrence rate of MR is signiﬁcant and it is related to the de-
gree of continued left ventricular remodelling. Furthermore,
the addition of mitral procedure to the revascularization may
increase the operative mortality and may not have any signif-
icant impact on long-term survival.
The present evidence however, strongly acknowledge that
moderate IMR is detrimental to survival and functional class.
The presence of moderate IMR is prognostic for poor survival
and functional class after CABG. Hence, we could safely con-
clude that moderate IMR without viable myocardium, should
be dealt at the time of revascularization using restrictive annu-
loplasty, provided that LVEDD is smaller than 65 mm. A ran-
domized prospective trial is necessary to clarify the role of
mitral valve repair in patients with moderate IMR with viable
myocardium undergoing CABG. Therefore, until such a trial isperformed, we recommend a low threshold for mitral valve re-
pair in such patient.References
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